An. Real. Acad. Farm. vol 80 nº 4 2014 - page 53

Riesgo y seguridad de la terapia avanzada
693
14.
Bernardo, ME.; Fibbe, WE. Safety and efficacy of mesenchymal stromal cell therapy in
autoimmune disorders. Ann N Y Acad Sci
1266
, 107-117 (2012).
15.
Benoit, E.; O'Donnell, TF.; Patel, AN. Safety and efficacy of autologous cell therapy in
critical limb ischemia: a systematic review. Cell Transplant,
22
(3), 545-562 (2013)
16.
Wu, C.; Dunbar, CE. Stem cell gene therapy: the risks of insertional mutagenesis and
approaches to minimize genotoxicity. Front Med
5
(4), 356-371 (2011).
17.
Mukherjee, S.; Thrasher AJ. Gene therapy for PIDs: progress, pitfalls and prospects. Gene
525
(2), 174-181 (2013).
1...,43,44,45,46,47,48,49,50,51,52 54,55,56,57,58,59,60,61,62,63,...134
Powered by FlippingBook